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Since Modine et al. [1] performed the first tran-
scarotid (TC) transcatheter aortic valve implantation 
(TAVI) in 2009, it has become a safe and reproducible 
alternative for patients not suitable for transfemoral 
access (TF) [1, 2]. Both self-expandable and balloon- 
-expandable transcatheter valves can be implanted 
through the common carotid artery. The majority of 
TC-TAVI are performed under general anesthesia [3], 
although a minimally invasive strategy (MIS) with 
local anesthesia and conscious sedation has also 
been reported [4]. Presented herein, are 2 cases 
of TC-TAVI implanted through the left common 
carotid artery (LCCA) under regional anesthesia at 
the Upper-Silesian Medical Center of the Medical 
University of Silesia in Katowice, Poland. 
Patient 1. An 81-year-old female, who was 
not eligible for aortic valve surgery because of 
frailty syndrome and cachexia with low body mass 
index (19 kg/m2). The patient presented with 
decompensated heart failure (New York heart 
Association [NYHA] class III). The perioperative 
risk was estimated at 4.6% and 5.7% (EuroSCORE 
and Society of Thoracic Surgeons [STS], respec-
tively). Transthoracic echocardiography (TTE) 
revealed severe aortic stenosis with aortic valve 
area (AVA) 0.65 cm2, Vmax 4.1 m/s, and mean 
gradient (PGmean) 40 mmHg. Left ventricular 
ejection fraction (LVEF) was 65%, and coronary 
angiography showed no significant stenosis. As 
multislice computed tomography (MSCT) imaging 
(Fig. 1A–C) revealed massive calcifications and 
critical stenosis of both iliac arteries, the patient 
was selected for TC-TAVI. The LCCA dimension 
was 6.1 mm, and there was no significant stenosis.
Patient 2. A 75-year-old male with severe aor-
tic stenosis (AVA 0.7 cm2, Vmax 3.1 m/s, PGmean 
28 mmHg), reduced to 35% LVEF, heart failure 
(NYHA III) and numerous comorbidities (history of 
several myocardial infarctions, multiple percutane-
ous coronary intervention with stent implantation, 
atrial fibrillation, pacemaker, left internal carotid 
artery occlusion, critical right internal carotid 
artery stenosis, type II diabetes mellitus, renal 
failure, hypertension and history of abdominal 
aorta aneurysm excision) was scheduled for the 
TAVI procedure via the LCCA (diameter 6.7 mm). 
The decision was made by the Heart Team based 
on MSCT (Fig. 1D–F). The STS score was 11.8% 
and EuroSCORE 36.4%. 
The MSCT images analysis, TC-TAVI surgery 
eligible criteria, intraoperative monitoring, and 
operation techniques did not differ from those 
reported in previous studies [5]. Both procedures 
were performed by a multidisciplinary specialist 
team in a hybrid operating room. No premedica-
tion was administered prior to the surgery. Basic 
parameters such as electrocardiogram, pulse 
oximetry, respiratory rate, invasive blood pressure 
monitoring were acquired with a Philips Intellli-
Vue monitor. Oxygen was supplemented through 
a nasal cannula. Preemptive multimodal analgesia 
with intravenous oxycodone (2 mg), paracetamol 
(1 g) and metamizole (1 g) was administered before 
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obtained under the ultrasound guidance. A Pajunk 
SonoTAP needle was inserted under the posterior 
border of the sternocleidomastoid muscle targeting 
the superficial cervical plexus and 20 mL of 0.5% 
Ropivacaine. The quality of the block was evaluated 
with the pinprick sensation test. 
Both procedures were successful, and no ma-
jor complications occurred during the surgery. Self- 
-expanding valves (Evolut R 26 and Evolut R 34; 
Medtronic, Inc., Minneapolis, Minnesota, USA) 
were implanted without pre- or post-dilatation. 
Both procedures’ duration was similar (60 and 
Figure 1. Periprocedural imaging. A. Three-dimensional (3D) reconstruction image of the multislice computed tomo-
graphy (MSCT) of the iliofemoral arteries and abdominal aorta in Patient 1; B. Image of the MSCT of the left carotid 
artery and aortic arch in Patient 1; C. Image of the MSCT dimensions of the aortic annulus in Patient 1; D. 3D re-
construction image of the MSCT of the iliofemoral arteries and abdominal aorta in Patient 2; E. Image of the MSCT 
dimensions of the aortic annulus in Patient 2; F. Image of the MSCT of the left carotid artery and aortic arch in Pa-
tient 2; G. Implanted aortic valve prosthesis in Patient 1; H. Image of the implanted aortic valve prosthesis in Patient 2; 
I. Image of the control left common carotid artery (LCCA) arteriography in Patient 1; J. Image of the control arterio-
graphy of the LCCA in Patient 2; K. Image of the control Doppler ultrasonography of the LCCA in Patient 1; L. Image 
of the control Doppler ultrasonography of the LCCA in Patient 2.
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55 min, respectively) (Fig. 1G, H). No neurologi-
cal incidents were observed in the perioperative 
period. The values of cerebral oximetry acquired 
during the MIS were comparable to those obtained 
during procedures under general anesthesia. 
Moreover, hemodynamic profiles of patients were 
stable, and no inotropic support was required. 
A control carotid angiography (Fig. 1I, J) showed 
normal flow in the LCCA of both patients. The 
postoperative renal function was preserved at 
normal levels (estimated glomerular filtration rate 
78 and 59 mL/min/1.73 m2, respectively). One pa-
tient had a postoperative complication unrelated to 
the carotid access. This concerned major bleeding 
per the Valve Academic Research Consortium-2 
consensus from the femoral artery after the re-
moval of the vascular sheath used for the pig-tail 
catheter [6]. The bleeding site was managed surgi-
cally, and the patient received two units of packed 
red blood cells. A TTE assessment confirmed the 
correct function of the implanted valves (PGmean 
5.2 mmHg and 7 mmHg, Vmax 1.8 m/s and 1.9 m/s), 
no paravalvular leak and no LVEF reduction in both 
patients. A Doppler ultrasound (Fig. 1K, L) showed 
the normal flow through the LCCA (low values of 
maximum systolic velocity and end-diastolic veloc-
ity). The patients were discharged home after 8 and 
6 days, respectively, with improved physical status 
(NYHA I and II, respectively). 
To this day, at the documented hospital, the 
vast majority of TC-TAVI (37 of 39) have been per-
formed under general anesthesia with endotracheal 
intubation. This seems to be comparable with the 
experience of other centers [3, 4]. In contrast to 
TF-TAVI, the TC-TAVI technique improves the 
implantation precision due to the short distance 
between the system insertion site and the aortic 
valve but requires the patient’s immobility. Thus, 
while general anesthesia eliminates the patient’s 
involuntary movements, it is the method of choice 
for uncooperative patients. The decision in the 
present cases to perform TC-TAVI under con-
scious sedation and local anesthesia was based 
on two reasons: in the cachectic Patient 1, there 
was a risk of the endotracheal tube misplacement 
in the trachea and making the LCCA difficult to 
be exposed. Additionally, in Patient 2 with diffuse 
carotid arteriosclerosis, MIS allowed for conscious 
cerebral function monitoring during the procedure. 
There are no clear guidelines concerning the 
anesthesia to be used in TC-TAVI. According to 
Azmoun et al. [7], MIS reduces respiratory com-
plications in older patients with frailty syndrome. 
In addition, although Debry et al. [4] showed a re-
duction of cerebrovascular incidents with MIS, this 
was not confirmed by the General Anesthesia ver-
sus Local Anesthesia for carotid surgery (GALA) 
study [8]. General anesthesia with low surgical 
impulsion can develop into hypotonia, increased 
demand for vasoactive agents, and consequently 
worsen kidney function, whilst patients under local 
anesthesia have an increased risk of hypoventila-
tion and aspiration [9].  
Our initial observations of TC-TAVI proce-
dures performed under conscious sedation and 
local anesthesia confirm that it can be safely 
performed by a well-trained Heart Team and an 
experienced anesthesiologist.
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